{"id":2715,"date":"2025-06-09T13:28:42","date_gmt":"2025-06-09T13:28:42","guid":{"rendered":"https:\/\/www.londoncataractcentre.co.uk\/blog\/?p=2715"},"modified":"2025-06-10T14:34:33","modified_gmt":"2025-06-10T14:34:33","slug":"autoimmune-disease-cataract-surgery","status":"publish","type":"post","link":"https:\/\/www.londoncataractcentre.co.uk\/blog\/autoimmune-disease-cataract-surgery\/","title":{"rendered":"Cataract Surgery Outcomes in Patients with Autoimmune Disease: What Does the Research Say?"},"content":{"rendered":"\n

Cataract surgery is one of the most commonly performed procedures in the world, and for most people, it delivers excellent results. But if you’re living with an autoimmune disease like lupus, rheumatoid arthritis (RA), or Sj\u00f6gren’s syndrome, your experience might look a little different. That\u2019s not to say you can\u2019t have a successful surgery\u2014far from it. However, your body\u2019s immune system, and the medications you may be taking to keep it in check, can change how you respond to surgery and how well you recover.<\/p>\n\n\n\n

In this article, we\u2019ll explore what current research says about cataract surgery outcomes in people with autoimmune diseases. We\u2019ll look at how these conditions affect the eye, what specific challenges surgeons face, and what the evidence tells us about post-operative risks. So if you’re managing an autoimmune disorder and thinking about cataract surgery, this deep dive should give you clarity\u2014both literally and figuratively.<\/p>\n\n\n\n

Understanding Autoimmune Disease and the Eye<\/strong><\/h2>\n\n\n\n

Before we jump into the surgery itself, let\u2019s talk about how autoimmune diseases impact the eye.<\/p>\n\n\n\n

Autoimmune conditions occur when your immune system mistakenly attacks your own tissues. In diseases like systemic lupus erythematosus (SLE), RA, and Sj\u00f6gren\u2019s syndrome, this attack often extends to the eyes. You might experience chronic inflammation, dry eyes, or damage to structures like the sclera, uvea, or even the retina.<\/p>\n\n\n\n

In RA, for instance, you may develop episcleritis or scleritis\u2014both inflammatory eye conditions that can complicate surgery. Lupus can cause secondary Sj\u00f6gren\u2019s syndrome, further drying out the ocular surface, while primary Sj\u00f6gren\u2019s may lead to severe keratoconjunctivitis sicca. These aren\u2019t just annoying symptoms\u2014they can affect healing and visual outcomes after cataract removal.<\/p>\n\n\n\n

Moreover, many patients with autoimmune conditions are on long-term immunosuppressants, corticosteroids, or antimalarials like hydroxychloroquine, which can also have ophthalmic side effects. It\u2019s a lot to juggle, but knowing this context helps make sense of the surgical risks.<\/p>\n\n\n\n

Pre-Operative Considerations in Autoimmune Patients<\/strong><\/h2>\n\n\n\n

Ocular Surface Disease and Dry Eye<\/strong><\/h3>\n\n\n\n

Let\u2019s start with something common but impactful: dry eye. People with Sj\u00f6gren\u2019s or lupus often suffer from moderate to severe dry eye disease (DED). A dry, inflamed ocular surface can make measurements less accurate, particularly for IOL power calculations. It also increases the risk of epithelial defects, delayed healing, and patient discomfort post-op.<\/p>\n\n\n\n

Treating dry eye aggressively before surgery\u2014using lubricating drops, anti-inflammatory eye drops, or even punctal plugs\u2014is critical to achieving good outcomes. Some surgeons may even delay the surgery until the tear film is stable enough to ensure accurate biometry.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Immunosuppressants and Steroid Use<\/strong><\/h3>\n\n\n\n

Systemic immunosuppression is a double-edged sword. On one hand, it controls inflammation. On the other, it increases infection risk and can affect wound healing. Corticosteroids, in particular, can impair collagen production and blunt the body\u2019s inflammatory response, sometimes masking early signs of infection or suture problems.<\/p>\n\n\n\n

The key here is close collaboration with your rheumatologist or immunologist. Your eye surgeon might ask for clearance or suggest adjusting dosages in the perioperative period to balance inflammation control with immune readiness.<\/p>\n\n\n\n

Comorbid Conditions<\/strong><\/h3>\n\n\n\n

Autoimmune disease rarely comes alone. Many patients have coexisting conditions like hypertension, renal impairment, or cardiovascular issues. These factors can further complicate anaesthesia and healing. Having a thorough pre-op workup\u2014including blood tests and a full systemic review\u2014is essential.<\/p>\n\n\n\n

Intraoperative Challenges<\/strong><\/h2>\n\n\n\n

Small Pupil and Poor Dilation<\/strong><\/h3>\n\n\n\n

Patients with RA and lupus often have poorly dilating pupils due to chronic inflammation or fibrosis of the iris. This can make it harder for the surgeon to access and remove the cataract safely. Techniques like pupil expansion devices, intracameral mydriatics, or iris hooks may be required.<\/p>\n\n\n\n

But using these tools increases surgical time and the risk of trauma to intraocular structures, so surgeons need to be particularly skilled and careful.<\/p>\n\n\n\n

Fragile Zonules and Capsule Weakness<\/strong><\/h3>\n\n\n\n

Chronic inflammation can affect the zonular fibres that hold the lens in place. In some autoimmune patients, especially those on long-term steroids, the lens capsule or supporting structures may be more fragile. This raises the risk of complications like capsular rupture or dropped lens fragments.<\/p>\n\n\n\n

To counter this, surgeons may use capsular tension rings or adopt a slower, more controlled phacoemulsification technique.<\/p>\n\n\n\n

Postoperative Complications: What the Literature Shows<\/strong><\/h2>\n\n\n\n

Increased Risk of Inflammation<\/strong><\/h3>\n\n\n\n

Even in uncomplicated cases, cataract surgery triggers inflammation. In autoimmune patients, this response can be exaggerated or prolonged. Studies have shown that people with RA and lupus may experience more intense anterior chamber reactions, cystoid macular oedema (CME), or delayed visual recovery.<\/p>\n\n\n\n

Topical corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) are often prescribed more aggressively post-op, sometimes alongside systemic medication adjustments. Monitoring for inflammation should be extended for several weeks beyond the typical post-op schedule.<\/p>\n\n\n\n

Higher Infection Risk<\/strong><\/h3>\n\n\n\n

Immunosuppressed patients have a higher baseline risk of infection, including rare but serious complications like endophthalmitis. Although the overall risk remains low, the consequences can be devastating. Strict aseptic technique, prophylactic antibiotics, and close monitoring are essential.<\/p>\n\n\n\n

Interestingly, some studies recommend intracameral antibiotics (e.g. cefuroxime or moxifloxacin) as an added layer of protection in these patients, given their reduced immune responsiveness.<\/p>\n\n\n\n

Delayed Wound Healing<\/strong><\/h3>\n\n\n\n

Especially in those on systemic steroids or methotrexate, wound healing can be slower than expected. This might show up as persistent corneal oedema, suture-related irritation (in cases requiring sutures), or ongoing epithelial defects.<\/p>\n\n\n\n

Again, this is where pre-op preparation and good communication between your ophthalmologist and rheumatologist can make a huge difference.<\/p>\n\n\n\n

Specific Evidence on Lupus and Cataract Surgery<\/strong><\/h2>\n\n\n\n

Systemic lupus erythematosus (SLE) is associated with a higher risk of cataract formation, partly due to chronic steroid use. But what does the literature say about outcomes?<\/p>\n\n\n\n

A 2020 study in Ophthalmology<\/em> followed 47 patients with lupus undergoing cataract surgery. The majority achieved good visual acuity (better than 6\/12) post-operatively. However, 26% experienced transient inflammation requiring prolonged steroid therapy, and 9% had post-op complications such as CME.<\/p>\n\n\n\n

Another paper from Clinical Rheumatology<\/em> found that patients with active SLE at the time of surgery had worse outcomes than those in remission. The takeaway? Timing matters. Surgery is safest and most effective when lupus is stable.<\/p>\n\n\n\n

Cataract Surgery in Rheumatoid Arthritis Patients<\/strong><\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n

Rheumatoid arthritis is perhaps the most extensively studied autoimmune condition in relation to cataract surgery.<\/p>\n\n\n\n

A landmark study published in Journal of Cataract & Refractive Surgery<\/em> in 2018 found that RA patients were more likely to have small pupils, dry eye, and delayed visual recovery. However, with proper management, 90% still achieved satisfactory vision post-op.<\/p>\n\n\n\n

Another systematic review noted a slightly higher incidence of posterior capsular opacification (PCO) in RA patients, potentially due to chronic inflammation. The recommendation? Regular YAG laser follow-up and careful selection of IOL materials with lower PCO rates.<\/p>\n\n\n\n

Sj\u00f6gren\u2019s Syndrome and Surgical Outcomes<\/strong><\/h2>\n\n\n\n

Sj\u00f6gren\u2019s syndrome poses one of the biggest challenges in cataract surgery due to severe dry eye disease.<\/p>\n\n\n\n

A 2022 review in Eye and Vision<\/em> journal highlighted several issues:<\/p>\n\n\n\n